Tuesday, October 6, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

Chattopadhyay's research focus will be gene therapy and rare diseases. Dr. Chattopadhyay joins Guggenheim from H.C. Wainwright & Co., where he ...
http://dlvr.it/Rj2Y7V
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...